Patent Category: Therapies

Use of Ifenprodil in the treatment of chronic seizures

03.09.2020

The invention relates to use of ifenprodil for the treatment of chronic or recurrent seizures that are a symptom of i.a. temporal lobe epilepsy (TLE), including, in particular, drug-resistant TLE. Approximately 50 million people worldwide suffer from epilepsy. In approximately 40% of patients, temporal lobe epilepsy (TLE) is resistant to currently available pharmacotherapies. An important factor in the pathogenesis of the disease is the small subpopulation of the receptor for ...

Use of Marimastat for preventing and/or treating epileptogenesis

03.09.2020

The present invention is related to use of marimastat or a pharmaceutically acceptable salt, solvate or polymorph thereof in preventing or treating epileptogenesis in a subject that suffered a ...

New peptide compounds as the agents stimulating healing of wounds and reconstruction of skin

01.09.2020

The subject of the patent application are new compounds with a biologically active sequence for accelerating wound healing. The subject of the patent application further includes a method of ...

Composition containing peptide IM, the set and application for stimulation of regeneration of a complex tissue or treatment of wounds

01.09.2020

The subject of the patent application is a pharmaceutical composition that contains an IM peptide at a concentration of 0.1 - 50 µg/ml and/or a pharmaceutically acceptable salt thereof and at ...

Chemical compounds with anti-damage and/or neuroprotective effects

01.09.2020

The present invention relates to chemical compounds with injury-reducing and/or neuroprotective properties. The compounds are preferably selected from the group: RGD1; RGD2; RGD3; RGD4; AcRGDl; ...